PHIO PHARMACEUTICALS CORP. Proceeds from Convertible Debt
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds from Convertible Debt of $500.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2014-03-28
- PHIO PHARMACEUTICALS CORP. proceeds from convertible debt for the quarter ending 2012-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from convertible debt for the quarter ending 2012-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from convertible debt for the quarter ending 2012-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from convertible debt for the quarter ending 2012-03-31 was $500.00K.
- PHIO PHARMACEUTICALS CORP. proceeds from convertible debt for fiscal 2012 was $500.00K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 117 month |
|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $500.00K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $500.00K 10-Q · filed 2013-11-14 | $1.00M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $500.00K 10-Q · filed 2013-08-14 | |||
| 2012-03-31 | $500.00K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |